• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Eric L. Sievers, Richard A. Larson, +13 authors Frederick R Appelbaum
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2001 (First Publication: 1 July 2001)
  • PURPOSE Three open-label, multicenter trials were conducted to evaluate the efficacy and safety of single-agent Mylotarg (gemtuzumab ozogamicin; CMA-676; Wyeth Laboratories, Philadelphia, PA), anContinue Reading
  • Pierre Fenaux, Ghulam J. Mufti, +13 authors Lewis R. Silverman
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2010 (First Publication: 1 February 2010)
  • PURPOSE In a phase III randomized trial, azacitidine significantly prolonged overall survival (OS) compared with conventional care regimens (CCRs) in patients with intermediate-2- and high-riskContinue Reading
  • Emmanuelle Clappier, Wendy Cuccuini, +15 authors Jean Soulier
  • Biology, Medicine
  • Blood
  • 2007 (First Publication: 15 August 2007)
  • The C-Myb transcription factor is essential for hematopoiesis, including in the T-cell lineage. The C-Myb locus is a common site of retroviral insertional mutagenesis, however no recurrent genomicContinue Reading
  • Oliver G Ottmann, Hervé Dombret, +9 authors Steven E. Coutré
  • Medicine
  • Blood
  • 2007 (First Publication: 1 October 2007)
  • Patients with Philadelphia (Ph) chromosome-positive acute lymphoblastic leukemia (ALL) have a rapid disease course and a poor prognosis. Dasatinib, a novel, oral, multitargeted kinase inhibitor ofContinue Reading
  • Françoise Huguet, Thibaut Leguay, +15 authors Hervé Dombret
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2009 (First Publication: 20 February 2009)
  • PURPOSE Retrospective comparisons have suggested that adolescents or teenagers with acute lymphoblastic leukemia (ALL) benefit from pediatric rather than adult chemotherapy regimens. Thus, the aim ofContinue Reading
  • Claude Preudhomme, Christophe Sagot, +9 authors Hervé Dombret
  • Medicine
  • Blood
  • 2002 (First Publication: 15 October 2002)
  • The transcription factor C/EBPalpha is crucial for differentiation of mature granulocytes. Recently, different CEBPA gene mutations likely to induce differentiation arrest have been described inContinue Reading